Bart Barlogie Selected Research

Bart Barlogie Research Topics

Disease

145	Multiple Myeloma 12/2023 - 02/2002
55	Neoplasms (Cancer) 01/2023 - 01/2002
20	Chromosome Aberrations (Chromosome Abnormalities) 01/2024 - 08/2002
10	Bone Diseases (Bone Disease) 09/2014 - 01/2002
8	Paraproteinemias (Monoclonal Gammopathy) 11/2020 - 02/2006
7	Disease Progression 01/2015 - 01/2002
6	Amyloidosis 06/2014 - 03/2002
5	Thrombocytopenia (Thrombopenia) 01/2024 - 12/2005
5	Waldenstrom Macroglobulinemia (Macroglobulinemia) 01/2018 - 04/2003
5	Anemia 01/2018 - 04/2003
5	Monoclonal Gammopathy of Undetermined Significance 01/2018 - 01/2002
5	Aspergillosis 10/2011 - 07/2007
4	Hematologic Neoplasms (Hematological Malignancy) 12/2019 - 07/2007
4	Smoldering Multiple Myeloma 01/2018 - 10/2008
4	Renal Insufficiency (Renal Failure) 11/2010 - 01/2003
4	Venous Thrombosis (Deep-Vein Thrombosis) 03/2006 - 08/2002
3	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 12/2019 - 01/2008
3	Leukemia 03/2015 - 08/2012
3	Bone Resorption 06/2013 - 02/2002
3	Testicular Neoplasms (Testicular Cancer) 05/2011 - 08/2002
3	Fatigue 05/2011 - 04/2003
3	Mucositis 02/2011 - 01/2003
3	Neoplasm Metastasis (Metastasis) 01/2008 - 12/2003
3	Thrombosis (Thrombus) 10/2007 - 06/2003
3	Peripheral Nervous System Diseases (PNS Diseases) 07/2006 - 04/2003
3	Infections 08/2004 - 03/2003
2	Carcinogenesis 01/2020 - 04/2006
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2019 - 06/2002
2	Plasmacytoma 01/2017 - 02/2007
2	Plasma Cell Leukemia 12/2015 - 06/2014
2	Castleman Disease (Castleman's Disease) 01/2013 - 07/2010
2	Severe Combined Immunodeficiency (Bare Lymphocyte Syndrome) 09/2012 - 12/2002
2	Venous Thromboembolism 01/2012 - 08/2006
2	Neutropenia 12/2010 - 08/2004
2	Activated Protein C Resistance (APC Resistance) 08/2006 - 06/2003

Drug/Important Bio-Agent (IBA)

27	Thalidomide (Thalomid)FDA Link 12/2023 - 04/2002
23	Bortezomib (Velcade)FDA Link 12/2023 - 06/2003
16	Dexamethasone (Maxidex)FDA LinkGeneric 12/2023 - 03/2003
14	Melphalan (Alkeran)FDA LinkGeneric 12/2023 - 03/2002
12	Lenalidomide (CC 5013)FDA Link 12/2023 - 10/2003
11	Proteins (Proteins, Gene)FDA Link 12/2016 - 05/2002
9	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 01/2024 - 03/2004
9	Proteasome InhibitorsIBA 09/2017 - 03/2005
8	AntigensIBA 01/2018 - 05/2002
5	Messenger RNA (mRNA)IBA 04/2010 - 02/2003
4	CytokinesIBA 01/2019 - 06/2003
4	Proteasome Endopeptidase Complex (Proteasome)IBA 12/2016 - 04/2009
4	galactomannanIBA 10/2011 - 07/2007
4	Immunoglobulins (Immunoglobulin)IBA 07/2008 - 06/2003
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2023 - 06/2003
3	AlbuminsIBA 01/2018 - 02/2011
3	CreatinineIBA 01/2018 - 03/2002
3	Immunomodulating AgentsIBA 09/2017 - 12/2002
3	DNA (Deoxyribonucleic Acid)IBA 04/2017 - 01/2004
3	Monoclonal AntibodiesIBA 01/2016 - 10/2006
3	Antineoplastic Agents (Antineoplastics)IBA 02/2011 - 08/2005
3	Cyclin D1IBA 02/2010 - 01/2003
3	Prednisone (Sone)FDA LinkGeneric 07/2009 - 05/2002
2	Etoposide (VP 16)FDA LinkGeneric 12/2023 - 06/2003
2	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2023 - 06/2003
2	Cisplatin (Platino)FDA LinkGeneric 12/2023 - 06/2003
2	RNA (Ribonucleic Acid)IBA 01/2023 - 10/2006
2	Immunoglobulin G (IgG)IBA 11/2020 - 10/2016
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 02/2007
2	Immunoglobulin M (IgM)IBA 01/2018 - 08/2014
2	Cyclin DIBA 04/2017 - 07/2005
2	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2017 - 08/2004
2	Histones (Histone)IBA 12/2016 - 05/2011
2	Immunoglobulin Heavy Chains (Immunoglobulin Heavy Chain)IBA 07/2014 - 07/2008
2	NF-kappa B (NF-kB)IBA 07/2013 - 08/2007
2	Indicators and Reagents (Reagents)IBA 01/2012 - 04/2004
2	Membrane Glycoproteins (Membrane Glycoprotein)IBA 01/2012 - 05/2008
2	Sodium Glutamate (Accent)IBA 10/2011 - 12/2010
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 12/2010 - 07/2006
2	VaccinesIBA 09/2010 - 11/2005
2	beta CateninIBA 03/2010 - 04/2009
2	Cyclin D3IBA 02/2010 - 01/2003
2	C-Reactive ProteinIBA 09/2009 - 10/2006
2	elotuzumabIBA 09/2009 - 05/2008
2	fludarabineIBA 12/2008 - 04/2003
2	LigandsIBA 12/2008 - 02/2002
2	Polysaccharides (Glycans)IBA 05/2008 - 07/2007
2	Heparitin Sulfate (Heparan Sulfate)IBA 09/2007 - 12/2003
2	heparanaseIBA 09/2007 - 12/2003
2	EnzymesIBA 09/2007 - 12/2003
2	Syndecan-1 (Syndecan 1)IBA 09/2007 - 12/2003
2	OligonucleotidesIBA 04/2007 - 12/2003
2	factor V LeidenIBA 08/2006 - 06/2003
2	Protein CIBA 08/2006 - 06/2003

Therapy/Procedure

95	Therapeutics 12/2023 - 01/2002
23	Drug Therapy (Chemotherapy) 03/2022 - 08/2002
10	Stem Cell Transplantation 03/2022 - 01/2002
7	Transplantation 12/2015 - 01/2002
7	Autologous Transplantation 08/2014 - 05/2003
6	Immunotherapy 09/2012 - 05/2002
3	Hematopoietic Stem Cell Transplantation 12/2023 - 03/2006
3	Cell Transplantation 12/2015 - 03/2006
2	Salvage Therapy 07/2013 - 10/2008
2	Induction Chemotherapy 02/2011 - 05/2002
2	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 05/2008 - 03/2004